Company Filing History:
Years Active: 1999
Title: Jensen Snej Klaus: Innovator in Pharmaceutical Chemistry
Introduction
Jensen Snej Klaus is a notable inventor based in Frederiksberg C, Denmark. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds aimed at improving health outcomes.
Latest Patents
Klaus holds a patent for a compound titled "Crystalline (-)-3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-2-(pyrrolidin-1-yl)ethoxy!phenyl}chromane, hydrogen fumarate." This invention is particularly useful for reducing or preventing bone loss and includes pharmaceutical compositions containing the compound. The patent outlines a process for preparing this innovative crystalline form.
Career Highlights
Jensen Snej Klaus is associated with Novo Nordisk A/S, a leading global healthcare company known for its focus on diabetes care and other chronic conditions. His work at Novo Nordisk has allowed him to contribute to advancements in pharmaceutical research and development.
Collaborations
Klaus has collaborated with esteemed colleagues such as Svend Treppendahl and Scott E McGraw. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical sector.
Conclusion
Jensen Snej Klaus is a prominent figure in pharmaceutical innovation, with a focus on developing compounds that address critical health issues. His contributions, particularly through his patent, reflect his commitment to advancing medical science and improving patient care.